The CRISPR companies are not OK
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.
Related Articles
New name for lifesaving procedure recognizes Black pioneer’s role
Vivien Thomas helped develop what’s long been known as the Blalock-Taussig shunt. More prominent recognition of his vital contribution is way overdue.
International Stroke Congress (ISC) Articles | JAMA Network
International Stroke Congress (ISC) Articles | JAMA Network International Stroke Conference (ISC) QUICK LINKS: Visit Us at ISC For Authors More Articles QUICK LINKS Visit…
Closing the Gap: Prepping Younger Med Students for Clinic
There’s a nationwide effort to better prepare undergrad medical students for the clinical experience.
Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries
Objective Quantify insulin glargine prices following the market introduction of biosimilars. Examine price levels and price changes for originator and biosimilars, by country. Methods Retrospective…
Patient Information: Pericarditis
This JAMA Patient Page describes pericarditis signs and symptoms, complications, diagnosis, and treatment.
5-Star Review of Dermatology – 2 Volume Set, 5th Edition – The Bookmark
Dermatology, 5th Edition By: Jean L. Bolognia, MD, Julie V. Schaffer, MD and Lorenzo Cerroni, MD ISBN: 9780702082252 Publication Date: April 23, 2024 Reviewer: Patricia…
Confronting the Neglect and Normalization of Chagas Disease in Bolivia – BMJ Global Health blog
This blog discusses the complex and structural causes of Chagas disease in Bolivia which lead to inequities
Bifidobacterium adolescentis-derived nicotinic acid improves host skeletal muscle mitochondrial function to ameliorate sarcopenia
Zhang et al. demonstrated that nicotinic acid derived from Bifidobacterium adolescentis increases oxidative muscle fibers in skeletal muscle and improves muscle health in individuals with sarcopenia…
FDA clinical trial inclusivity guidelines will be back
Medicine can’t be a miracle that works for only part of the population and leaves the balance in the dark.
‘We can’t do this alone’: Hospitals share lessons from Hurricane Helene to prepare for extreme weather events
Months before Hurricane Helene would devastate the Southeast, the Institute for Healthcare Improvement was launching its Chief Quality Officer Network. | The storm decimated half…
